Histamine H3 receptor blockade improves cardiac function in canine anaphylaxis.

Area of Science:

• Cardiovascular Physiology
• Allergy and Immunology
• Pharmacology

Background:

• Anaphylactic shock (AS) involves complex autacoid actions, with unclear roles for histamine, prostaglandins, and leukotrienes in cardiovascular collapse.
• The efficacy of receptor blockers and pathway inhibitors in mitigating AS-induced cardiovascular dysfunction requires further investigation.

Purpose of the Study:

• To investigate the role of histamine receptors (H1, H2, H3) and inflammatory pathways in preventing left ventricular (LV) contractility depression during anaphylaxis.
• To determine if blocking specific histamine receptors or inflammatory pathways can prevent cardiovascular collapse in a ragweed-induced anaphylaxis model.

Main Methods:

• Utilized a ragweed-induced anaphylaxis model in animals under pentobarbital anesthesia.
• Administered H1, H2, H3 receptor blockers, cyclooxygenase, and leukotriene pathway inhibitors prior to allergen challenge.
• Measured left ventricular (LV) volumes using sonomicrometry, alongside mean arterial pressure (Pa), cardiac output (Q), and LV end-diastolic pressure (LVEDP).

Main Results:

• All treatments resulted in a ~50% decrease in Pa, Q, and LVEDP during anaphylactic shock compared to baseline.
• Histamine H3 receptor blockade significantly increased heart rate (HR) and stroke work (SW) (p < 0.05) compared to other treatment groups.
• This suggests a protective effect of H3 blockade on cardiac function during anaphylaxis.

Conclusions:

• Histamine H3 receptor activation contributes to cardiovascular collapse in anaphylactic shock.
• H3 receptor blockade may mitigate cardiovascular dysfunction by preventing the inhibition of adrenergic neural norepinephrine release.
• Targeting histamine H3 receptors presents a potential therapeutic strategy for managing anaphylactic shock.